应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
HCC Warrior Met Coal LLC
交易中 02-05 13:12:26 EST
86.03
-2.37
-2.69%
最高
86.77
最低
84.14
成交量
63.99万
今开
85.32
昨收
88.40
日振幅
2.98%
总市值
45.22亿
流通市值
44.27亿
总股本
5,257万
成交额
5,468万
换手率
1.24%
流通股本
5,147万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
财报前瞻|Warrior Met Coal LLC本季营收预计增长23.62%,机构观点偏多
财报Agent · 02-05 11:04
财报前瞻|Warrior Met Coal LLC本季营收预计增长23.62%,机构观点偏多
Warrior Met Coal蓝溪一号矿区租赁面积达8300英亩,可开采煤炭储量3630万短吨
美股速递 · 01-14
Warrior Met Coal蓝溪一号矿区租赁面积达8300英亩,可开采煤炭储量3630万短吨
复宏汉霖(02696):伊匹木单抗生物类似药HLX13(重组抗CTLA-4全人单克隆抗体注射液)一线治疗不可切除的肝细胞癌(HCC)患者的国际多中心1期临床研究于中国境内完成首例患者给药
智通财经 · 2025-11-25
复宏汉霖(02696):伊匹木单抗生物类似药HLX13(重组抗CTLA-4全人单克隆抗体注射液)一线治疗不可切除的肝细胞癌(HCC)患者的国际多中心1期临床研究于中国境内完成首例患者给药
复宏汉霖(02696):HLX13一线治疗不可切除的肝细胞癌(HCC)患者的1期临床试验申请获美国FDA批准
智通财经网 · 2025-09-29
复宏汉霖(02696):HLX13一线治疗不可切除的肝细胞癌(HCC)患者的1期临床试验申请获美国FDA批准
和誉-B盘中异动 早盘快速上涨5.08%
市场透视 · 2025-08-29
和誉-B盘中异动 早盘快速上涨5.08%
远大医药尾盘涨超7% 今日盘后将发中期业绩 机构看好公司进入加速发展阶段
智通财经 · 2025-08-19
远大医药尾盘涨超7% 今日盘后将发中期业绩 机构看好公司进入加速发展阶段
维立志博涨超5% 近日奥帕替苏米单抗关键注册临床研究完成全部受试者入组
智通财经 · 2025-08-18
维立志博涨超5% 近日奥帕替苏米单抗关键注册临床研究完成全部受试者入组
Warrior Met Coal, Inc.8月11日成交额为6818.12万美元
市场透视 · 2025-08-12
Warrior Met Coal, Inc.8月11日成交额为6818.12万美元
Can Fite Biopharma Ltd盘中异动 股价大跌5.06%报1.50美元
市场透视 · 2025-03-11
Can Fite Biopharma Ltd盘中异动 股价大跌5.06%报1.50美元
Can Fite Biopharma Ltd盘中异动 快速下跌6.98%报1.60美元
市场透视 · 2025-03-04
Can Fite Biopharma Ltd盘中异动 快速下跌6.98%报1.60美元
Warrior Met Coal, Inc.盘中异动 早盘急速拉升5.23%
市场透视 · 2025-03-03
Warrior Met Coal, Inc.盘中异动 早盘急速拉升5.23%
Can Fite Biopharma Ltd盘中异动 大幅上涨5.11%报1.85美元
市场透视 · 2025-02-28
Can Fite Biopharma Ltd盘中异动 大幅上涨5.11%报1.85美元
Can Fite Biopharma Ltd盘中异动 大幅下挫6.07%
市场透视 · 2025-02-24
Can Fite Biopharma Ltd盘中异动 大幅下挫6.07%
Warrior Met Coal, Inc.盘中异动 早盘大幅拉升11.71%报51.53美元
市场透视 · 2025-02-24
Warrior Met Coal, Inc.盘中异动 早盘大幅拉升11.71%报51.53美元
Can Fite Biopharma Ltd盘中异动 急速上涨6.28%
市场透视 · 2025-02-21
Can Fite Biopharma Ltd盘中异动 急速上涨6.28%
Warrior Met Coal, Inc.2024财年实现净利润2.51亿美元,同比减少47.60%
市场透视 · 2025-02-18
Warrior Met Coal, Inc.2024财年实现净利润2.51亿美元,同比减少47.60%
Warrior Met Coal, Inc.盘中异动 股价大跌5.10%
市场透视 · 2025-02-14
Warrior Met Coal, Inc.盘中异动 股价大跌5.10%
异动解读 | Warrior Met Coal 2024年Q4财报疲软 股价盘后大跌5.56%
异动解读 · 2025-02-14
异动解读 | Warrior Met Coal 2024年Q4财报疲软 股价盘后大跌5.56%
Warrior Met Coal(HCC.US):2024年Q4财报实现营收2.975亿美元,前值为3.638亿美元,预期值为3.067亿美元;每股收益为0.15美元,前值为2.49美元,预期值为0.46美元。
金融界 · 2025-02-14
Warrior Met Coal(HCC.US):2024年Q4财报实现营收2.975亿美元,前值为3.638亿美元,预期值为3.067亿美元;每股收益为0.15美元,前值为2.49美元,预期值为0.46美元。
Warrior Met Coal第四季度调整后每股收益$0.15低于预期$0.43,销售额为$2.9746亿低于预期$3.0674亿
财报速递 · 2025-02-14
Warrior Met Coal第四季度调整后每股收益$0.15低于预期$0.43,销售额为$2.9746亿低于预期$3.0674亿
暂无数据
公司概况
公司名称:
Warrior Met Coal LLC
所属市场:
NYSE
上市日期:
--
主营业务:
Warrior Met Coal, Inc.成立于特拉华州,是总部位于阿拉巴马州布鲁克伍德的全球钢铁行业的美国环保和社会意识供应商。他们完全致力于开采非热炼钢煤,这些煤是欧洲、南美和亚洲金属制造商钢铁生产的关键组成部分。他们是一家大规模、低成本的优质冶金或炼钢煤生产商和出口商。
发行价格:
--
{"stockData":{"symbol":"HCC","market":"US","secType":"STK","nameCN":"Warrior Met Coal LLC","latestPrice":86.025,"timestamp":1770315142665,"preClose":88.4,"halted":0,"volume":639939,"delay":0,"changeRate":-0.02686651583710407,"floatShares":51466215,"shares":52570156,"eps":0.669006,"marketStatus":"交易中","change":-2.375,"latestTime":"02-05 13:12:26 EST","open":85.32,"high":86.77,"low":84.14,"amount":54681168.504329994,"amplitude":0.029751,"askPrice":86.06,"askSize":10,"bidPrice":85.86,"bidSize":1,"shortable":3,"etf":0,"ttmEps":0.669006,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770325200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":720248400000,"exchange":"NYSE","adjPreClose":88.4,"dividendRate":0.00372,"preHourTrading":{"tag":"盘前","latestPrice":86.25,"preClose":88.4,"latestTime":"09:29 EST","volume":2381,"amount":205547.94421000002,"timestamp":1770301762959,"change":-2.15,"changeRate":-0.024321,"amplitude":0.037783},"postHourTrading":{"tag":"盘后","latestPrice":88.65,"preClose":88.4,"latestTime":"19:45 EST","volume":12614,"amount":1115124.5225,"timestamp":1770252359194,"change":0.25,"changeRate":0.002828,"amplitude":0.002828},"volumeRatio":1.125386,"impliedVol":0.6907,"impliedVolPercentile":0.9562},"requestUrl":"/m/hq/s/HCC/tweets","defaultTab":"tweets","newsList":[{"id":"1160230167","title":"财报前瞻|Warrior Met Coal LLC本季营收预计增长23.62%,机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1160230167","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160230167?lang=zh_cn&edition=full","pubTime":"2026-02-05 11:04","pubTimestamp":1770260644,"startTime":"0","endTime":"0","summary":"Warrior Met Coal LLC将于2026年02月12日发布财报,市场正在关注营收与利润弹性及成本端变化对盈利的影响。市场一致预期显示,本季度Warrior Met Coal LLC营收预计为3.79亿美元,同比增长23.62%;EBIT预计为2,620.76万美元,同比增长18.72%;调整后每股收益预计为0.53美元,同比增长22.50%。上季度Warrior Met Coal LLC营收为3.29亿美元,同比增长0.27%;毛利率为24.69%;归属母公司净利润为3,659.80万美元,净利率为11.15%;调整后每股收益为0.70美元,同比下降12.50%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|Warrior Met Coal LLC本季营收预计增长23.62%,机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCC"],"gpt_icon":0},{"id":"1169318726","title":"Warrior Met Coal蓝溪一号矿区租赁面积达8300英亩,可开采煤炭储量3630万短吨","url":"https://stock-news.laohu8.com/highlight/detail?id=1169318726","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169318726?lang=zh_cn&edition=full","pubTime":"2026-01-14 05:57","pubTimestamp":1768341431,"startTime":"0","endTime":"0","summary":"Warrior Met Coal LLC宣布,其蓝溪一号矿区(Blue Creek Mine No. 1)的租赁范围涵盖8300英亩土地,经评估确认该区域蕴藏高达3630万短吨的可开采煤炭储量。这一数据凸显了矿区巨大的资源潜力,为未来长期开采活动奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","HCC"],"gpt_icon":0},{"id":"2586428957","title":"复宏汉霖(02696):伊匹木单抗生物类似药HLX13(重组抗CTLA-4全人单克隆抗体注射液)一线治疗不可切除的肝细胞癌(HCC)患者的国际多中心1期临床研究于中国境内完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2586428957","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586428957?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:33","pubTimestamp":1764059593,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复宏汉霖 发布公告,近日,公司自主研发的伊匹木单抗生物类似药HLX13一线治疗不可切除的肝细胞癌患者的国际多中心1期临床研究于中国境内完成首例患者给药。本研究为一项国际多中心、随机、双盲、平行对照1期临床研究,旨在评价 HLX13或其原研药YERVOY 分别联合OPDIVO ,在既往未经治疗的不可切除的晚期肝细胞癌患者中的药代动力学特征、安全性、疗效和免疫原性的相似性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000165453.HKD","HCC","BK1161","02696","BK4006"],"gpt_icon":0},{"id":"2571385843","title":"复宏汉霖(02696):HLX13一线治疗不可切除的肝细胞癌(HCC)患者的1期临床试验申请获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2571385843","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571385843?lang=zh_cn&edition=full","pubTime":"2025-09-29 17:02","pubTimestamp":1759136574,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复宏汉霖(02696)公布,近日,公司自主研发的伊匹木单抗生物类似药HLX13(重组抗CTLA-4全人单克隆抗体注射液)(HLX13)一线治疗不可切除的肝细胞癌(HCC)患者的1期临床试验申请(IND)获美国食品药品管理局(FDA)批准。公司拟于条件具备后于美国开展该国际多中心临床试验。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02696","HCC","BK4006","BK1161"],"gpt_icon":0},{"id":"2563092383","title":"和誉-B盘中异动 早盘快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563092383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563092383?lang=zh_cn&edition=full","pubTime":"2025-08-29 10:15","pubTimestamp":1756433751,"startTime":"0","endTime":"0","summary":"2025年08月29日早盘10时15分,和誉-B股票出现异动,股价快速拉升5.08%。截至发稿,该股报16.750港元/股,成交量198.2万股,换手率0.29%,振幅4.58%。机构评级方面,在所有8家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。和誉-B股票所在的生物技术行业中,整体涨幅为0.42%。该公司拥有两款核心候选产品ABSK011和 ABSK091,以及12款其他在研产品。ABSK091 是一种分子靶向候选产品,也是 FGFR亚型 1、2和3的强效和选择性抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082910155195045dda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082910155195045dda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCC","BK4006"],"gpt_icon":0},{"id":"2560197036","title":"远大医药尾盘涨超7% 今日盘后将发中期业绩 机构看好公司进入加速发展阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2560197036","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560197036?lang=zh_cn&edition=full","pubTime":"2025-08-19 15:57","pubTimestamp":1755590273,"startTime":"0","endTime":"0","summary":"远大医药股价绩前抢跑,尾盘涨幅扩大逾7%。消息面上,远大医药拟于8月19日举行董事会会议批准中期业绩。天风证券此前指出,公司在核药板块已建立完整产业链,核心产品易甘泰钇[90Y]微球注射液用于治疗不可切除HCC和结直肠癌肝转移患者的核素介入治疗手段,产品2022年于国内获批上市后快速放量,截至2024年末,已累计治疗近2000例患者,2024年实现近5亿元销售收入。该行看好公司进入加速发展阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819161230a6eea6a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819161230a6eea6a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4006","HCC"],"gpt_icon":0},{"id":"2560797762","title":"维立志博涨超5% 近日奥帕替苏米单抗关键注册临床研究完成全部受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2560797762","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560797762?lang=zh_cn&edition=full","pubTime":"2025-08-18 14:38","pubTimestamp":1755499101,"startTime":"0","endTime":"0","summary":"维立志博涨超5%,截至发稿,涨4.54%,报72.5港元,成交额8642.91万港元。消息面上,据维立志博官微消息,8月14日,公司宣布,奥帕替苏米单抗单臂关键注册临床研究已完成全部受试者入组。据介绍,奥帕替苏米单抗是一种PD-L1与4-1BB双靶向双特异性抗体,为全球首款已处于单臂关键性临床阶段的靶向共刺激受体4-1BB的分子,有望成为治疗EP-NEC的首款获批药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818145345a6ec64f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818145345a6ec64f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2298321311.HKD","OC","LU1917777945.USD","LU1974910355.USD","LU2360108059.USD","LU2092937221.SGD","IE00BGHQF417.EUR","LU2106854487.HKD","LU2041044095.USD","BTC","IE00B3CCJ633.GBP","BK4006","LU2023250504.SGD","HCC","LU2023250843.SGD","LU2048586759.USD","LU0868494617.USD","BK4086","IE00B2PGVK34.USD"],"gpt_icon":0},{"id":"2558690983","title":"Warrior Met Coal, Inc.8月11日成交额为6818.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558690983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558690983?lang=zh_cn&edition=full","pubTime":"2025-08-12 10:47","pubTimestamp":1754966842,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日,Warrior Met Coal, Inc.成交额为6818.12万美元,成交额较昨日减少11.62%,当日成交量为113.87万股。Warrior Met Coal, Inc.于2025年8月11日跌0.69%,报60.31美元,该股过去5个交易日涨14.59%,年初至今涨11.72%,过去60日涨27.51%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-08-11|6818.12万|-11.62%|113.87万|#|2025-08-08|7714.64万|-38.85%|125.35万|#|2025-08-07|1.26亿|42.37%|212.68万|#|2025-08-06|8861.59万|47.34%|163.19万|#|2025-08-05|6014.34万|51.38%|111.03万|Warrior Met Coal Inc是一家总部位于美国的公司。该公司生产并出口在阿拉巴马州经营地下煤矿的冶金煤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812104723a6e0ae53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812104723a6e0ae53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4006","HCC"],"gpt_icon":0},{"id":"2518696201","title":"Can Fite Biopharma Ltd盘中异动 股价大跌5.06%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518696201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518696201?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:00","pubTimestamp":1741629613,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时00分,Can Fite Biopharma Ltd股票出现异动,股价快速下跌5.06%。截至发稿,该股报1.50美元/股,成交量3.0409万股,换手率0.50%,振幅6.82%。Can Fite Biopharma Ltd股票所在的生物技术行业中,整体涨幅为0.78%。Can Fite Biopharma Ltd公司简介:Can Fite Biofarma Ltd 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311020014a26a8866&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311020014a26a8866&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCC","BK4006","CANF","BK4139"],"gpt_icon":0},{"id":"2516603010","title":"Can Fite Biopharma Ltd盘中异动 快速下跌6.98%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516603010","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516603010?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:24","pubTimestamp":1741101861,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时24分,Can Fite Biopharma Ltd股票出现异动,股价大幅跳水6.98%。截至发稿,该股报1.60美元/股,成交量2.0657万股,换手率0.34%,振幅2.91%。Can Fite Biopharma Ltd股票所在的生物技术行业中,整体涨幅为0.39%。Can Fite Biopharma Ltd公司简介:Can Fite Biofarma Ltd 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232422989bbade&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232422989bbade&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4006","HCC","BK4139","CANF"],"gpt_icon":0},{"id":"2516344716","title":"Warrior Met Coal, Inc.盘中异动 早盘急速拉升5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516344716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516344716?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:33","pubTimestamp":1741012427,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时33分,Warrior Met Coal, Inc.股票出现波动,股价急速拉升5.23%。截至发稿,该股报50.66美元/股,成交量2.0078万股,换手率0.04%,振幅0.53%。Warrior Met Coal, Inc.股票所在的焦练煤行业中,整体涨幅为1.28%。其相关个股中,Warrior Met Coal, Inc.、Ramaco Resources, Inc.、Suncoke Energy, Inc.涨幅较大,American Resources Corporation、Warrior Met Coal, Inc.、Alpha Metallurgical Resources, Inc.较为活跃,换手率分别为0.64%、0.04%、0.03%,振幅较大的相关个股有American Resources Corporation、Ramaco Resources, Inc.、Suncoke Energy, Inc.,振幅分别为3.93%、2.24%、0.61%。Warrior Met Coal, Inc.公司简介:Warrior Met Coal Inc是一家总部位于美国的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223347989a1010&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223347989a1010&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4006","HCC"],"gpt_icon":0},{"id":"2514376958","title":"Can Fite Biopharma Ltd盘中异动 大幅上涨5.11%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514376958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514376958?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:45","pubTimestamp":1740757506,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时45分,Can Fite Biopharma Ltd股票出现异动,股价急速上涨5.11%。截至发稿,该股报1.85美元/股,成交量3.043万股,换手率0.50%,振幅4.32%。Can Fite Biopharma Ltd股票所在的生物技术行业中,整体涨幅为0.19%。Can Fite Biopharma Ltd公司简介:Can Fite Biofarma Ltd 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228234506abe0fc16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228234506abe0fc16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HCC","BK4006","CANF"],"gpt_icon":0},{"id":"2513720452","title":"Can Fite Biopharma Ltd盘中异动 大幅下挫6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720452?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:05","pubTimestamp":1740409507,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时05分,Can Fite Biopharma Ltd股票出现异动,股价大幅下挫6.07%。截至发稿,该股报1.70美元/股,成交量2.9367万股,换手率0.48%,振幅5.25%。Can Fite Biopharma Ltd股票所在的生物技术行业中,整体涨幅为0.45%。其相关个股中,Pepgen Inc.、Telix Pharmaceutic、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为161.52%、71.01%、25.66%,振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ,振幅分别为137.23%、55.69%、42.86%。Can Fite Biopharma Ltd公司简介:Can Fite Biofarma Ltd 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242305089890fe29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242305089890fe29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4006","CANF","HCC","BK4139"],"gpt_icon":0},{"id":"2513722744","title":"Warrior Met Coal, Inc.盘中异动 早盘大幅拉升11.71%报51.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513722744?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:31","pubTimestamp":1740407497,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时31分,Warrior Met Coal, Inc.股票出现异动,股价快速拉升11.71%。截至发稿,该股报51.53美元/股,成交量17.3023万股,换手率0.33%,振幅4.15%。Warrior Met Coal, Inc.股票所在的焦练煤行业中,整体涨幅为4.38%。其相关个股中,Warrior Met Coal, Inc.、Alpha Metallurgical Resources, Inc.、American Resources Corporation涨幅较大,Warrior Met Coal, Inc.、American Resources Corporation、Alpha Metallurgical Resources, Inc.较为活跃,换手率分别为0.33%、0.07%、0.04%,振幅较大的相关个股有Warrior Met Coal, Inc.、American Resources Corporation、Ramaco Resources, Inc.,振幅分别为4.15%、3.43%、1.44%。Warrior Met Coal, Inc.公司简介:Warrior Met Coal Inc 是一家美国公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223137abdb0dbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223137abdb0dbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCC","BK4006"],"gpt_icon":0},{"id":"2513296146","title":"Can Fite Biopharma Ltd盘中异动 急速上涨6.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513296146?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:42","pubTimestamp":1740148975,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时42分,Can Fite Biopharma Ltd股票出现异动,股价急速拉升6.28%。截至发稿,该股报2.03美元/股,成交量9.3133万股,换手率1.53%,振幅3.78%。Can Fite Biopharma Ltd股票所在的生物技术行业中,整体涨幅为0.31%。Can Fite Biopharma Ltd公司简介:Can Fite Biofarma Ltd 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224255a24eb32f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224255a24eb32f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CANF","BK4006","HCC"],"gpt_icon":0},{"id":"2512780926","title":"Warrior Met Coal, Inc.2024财年实现净利润2.51亿美元,同比减少47.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512780926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512780926?lang=zh_cn&edition=full","pubTime":"2025-02-18 00:00","pubTimestamp":1739808034,"startTime":"0","endTime":"0","summary":"2月18日,Warrior Met Coal, Inc.公布财报,公告显示公司2024财年净利润为2.51亿美元,同比减少47.60%;其中营业收入为15.27亿美元,同比减少9.00%,每股基本收益为4.79美元。从资产负债表来看,Warrior Met Coal, Inc.总负债5.01亿美元,其中短期债务13.21百万美元,资产负债比为5.18,流动比率为5.08。机构评级:截至2025年2月18日,当前有5家机构对Warrior Met Coal, Inc.目标价做出预测,其中目标均价为71.80美元,其中最低目标价为62.00美元,最高目标价为90.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218000041abd26a45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218000041abd26a45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCC"],"gpt_icon":0},{"id":"2511696405","title":"Warrior Met Coal, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511696405?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:31","pubTimestamp":1739543492,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时31分,Warrior Met Coal, Inc.股票出现异动,股价大幅跳水5.10%。截至发稿,该股报51.33美元/股,成交量5.5813万股,换手率0.11%,振幅1.31%。Warrior Met Coal, Inc.股票所在的焦练煤行业中,整体跌幅为1.23%。其相关个股中,Ramaco Resources, Inc.、Suncoke Energy, Inc.、Alpha Metallurgical Resources, Inc.涨幅较大,Warrior Met Coal, Inc.、Alpha Metallurgical Resources, Inc.、Ramaco Resources, Inc.较为活跃,换手率分别为0.12%、0.04%、0.03%,振幅较大的相关个股有American Resources Corporation、Warrior Met Coal, Inc.、Ramaco Resources, Inc.,振幅分别为4.53%、2.05%、1.80%。Warrior Met Coal, Inc.公司简介:Warrior Met Coal Inc 是一家美国公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223133abcf0646&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223133abcf0646&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4006","HCC"],"gpt_icon":0},{"id":"1121993851","title":"异动解读 | Warrior Met Coal 2024年Q4财报疲软 股价盘后大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=1121993851","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121993851?lang=zh_cn&edition=full","pubTime":"2025-02-14 05:56","pubTimestamp":1739483785,"startTime":"0","endTime":"0","summary":"Warrior Met Coal LLC股价在2025年2月13日(周四)收盘后大幅下挫5.56%,引发了市场的广泛关注。公司发布的2024年第四季度财报令投资者颇为失望。财报显示,Warrior Met Coal当季营收仅为2.975亿美元,低于分析师预期值3.067亿美元,同比去年同期的3.638亿美元下滑18.23%。疲软的财报数据打击了市场对Warrior Met Coal未来增长的信心。该公司营收和净利润均大幅滑落,未能达到市场预期,这令投资者对该公司的业绩增长和盈利能力存疑,从而选择抛售该股股票,最终导致其大跌收盘。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HCC"],"gpt_icon":0},{"id":"2511508449","title":"Warrior Met Coal(HCC.US):2024年Q4财报实现营收2.975亿美元,前值为3.638亿美元,预期值为3.067亿美元;每股收益为0.15美元,前值为2.49美元,预期值为0.46美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511508449","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511508449?lang=zh_cn&edition=full","pubTime":"2025-02-14 05:43","pubTimestamp":1739482991,"startTime":"0","endTime":"0","summary":"Warrior Met Coal(HCC.US):2024年Q4财报实现营收2.975亿美元,前值为3.638亿美元,预期值为3.067亿美元;每股收益为0.15美元,前值为2.49美元,预期值为0.46美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14054348151092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["HCC"],"gpt_icon":0},{"id":"1104593001","title":"Warrior Met Coal第四季度调整后每股收益$0.15低于预期$0.43,销售额为$2.9746亿低于预期$3.0674亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1104593001","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104593001?lang=zh_cn&edition=full","pubTime":"2025-02-14 05:31","pubTimestamp":1739482263,"startTime":"0","endTime":"0","summary":"Warrior Met Coal报告季度每股收益为$0.15,低于分析师普遍预期的$0.43,低65.12%。与去年同期的每股收益$2.49相比下降了93.98%。以上内容来自Benzinga Earnings专栏,原文如下:Warrior Met Coal reported quarterly earnings of $0.15 per share which missed the analyst consensus estimate of $0.43 by 65.12 percent. This is a 93.98 percent decrease over earnings of $2.49 per share from the same period last year. The company reported quarterly sales of $297.46 million which missed the analyst consensus estimate of $306.74 million by 3.02 percent. This is a 18.23","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Warrior Met Coal第四季度调整后每股收益$0.15低于预期$0.43,销售额为$2.9746亿低于预期$3.0674亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.warriormetcoal.com","stockEarnings":[{"period":"1week","weight":-0.0188},{"period":"1month","weight":-0.0171},{"period":"3month","weight":0.0873},{"period":"6month","weight":0.4556},{"period":"1year","weight":0.6711},{"period":"ytd","weight":0.0026}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0022},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.0769},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.0063}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Warrior Met Coal, Inc.成立于特拉华州,是总部位于阿拉巴马州布鲁克伍德的全球钢铁行业的美国环保和社会意识供应商。他们完全致力于开采非热炼钢煤,这些煤是欧洲、南美和亚洲金属制造商钢铁生产的关键组成部分。他们是一家大规模、低成本的优质冶金或炼钢煤生产商和出口商。","yearOnYearQuotes":[{"month":1,"riseRate":0.777778,"avgChangeRate":0.047428},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.010016},{"month":3,"riseRate":0.375,"avgChangeRate":-0.047162},{"month":4,"riseRate":0.5,"avgChangeRate":-0.00691},{"month":5,"riseRate":0.444444,"avgChangeRate":0.012171},{"month":6,"riseRate":0.666667,"avgChangeRate":0.009594},{"month":7,"riseRate":0.777778,"avgChangeRate":0.07587},{"month":8,"riseRate":0.444444,"avgChangeRate":0.020482},{"month":9,"riseRate":0.666667,"avgChangeRate":0.034825},{"month":10,"riseRate":0.555556,"avgChangeRate":0.03995},{"month":11,"riseRate":0.666667,"avgChangeRate":0.081356},{"month":12,"riseRate":0.777778,"avgChangeRate":0.058477}],"exchange":"NYSE","name":"Warrior Met Coal LLC","nameEN":"Warrior Met Coal LLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Warrior Met Coal LLC(HCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Warrior Met Coal LLC(HCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Warrior Met Coal LLC,HCC,Warrior Met Coal LLC股票,Warrior Met Coal LLC股票老虎,Warrior Met Coal LLC股票老虎国际,Warrior Met Coal LLC行情,Warrior Met Coal LLC股票行情,Warrior Met Coal LLC股价,Warrior Met Coal LLC股市,Warrior Met Coal LLC股票价格,Warrior Met Coal LLC股票交易,Warrior Met Coal LLC股票购买,Warrior Met Coal LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Warrior Met Coal LLC(HCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Warrior Met Coal LLC(HCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}